In the field of drug discovery, three-dimensional (3D) organoid development is one of the most important advancements so far. The ability of 3D organoids to self-organize and mimic functional organ cell types is felt to better represent in vivo biology than 2D monolayer cell cultures.
Download the eBook
As a result, organoids are playing an increasingly important role in the cancer research, neurobiology, stem cell research, and drug discovery sectors. They can provide important insights into tissue development and disease mechanisms, and offer a very valuable approach in terms of drug development and biological research.
Driven by fast-paced developments in advanced cell technologies and the goal to create models that will more closely resemble in vivo tissue, organoids are increasingly at the forefront of disease modeling and drug discovery.
As organoids have been developed that can represent a wide range of organs of the human body, new applications are expected to expand in numbers over the next few years.
Organoids have the potential to be the foundation of future innovations in precision, translational, and regenerative medicine.
This eBook functions as an essential guide to organoids for drug discovery.
Download the eBook
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.